$USNA

Insider Selling: USANA Health Sciences (NYSE:USNA) Director Sells 1,058 Shares of Stock

USANA Health Sciences (NYSE:USNA) Director Gilbert Fuller sold 1,058 shares of company stock on March 20th, 2026, for a total of $17,986.00 at an average price of $17.00 per share. The stock traded down to $16.88, near its 52-week low, despite the company beating quarterly EPS expectations. Institutional investors hold over 54% of the shares, and analyst ratings are mixed.

Original reporting
MarketBeat · MarketBeat
Published Mar 21, 2026, 12:35 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Mar 21, 2026, 1:00 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Insider Selling: USANA Health Sciences (NYSE:USNA) Director Sells 1,058 Shares of Stock — source image
Decision brief

The 30-second read

$USNANeutralLow
01

Why it matters

The insider sale amid a stock trading near its low and earnings beat suggests a cautious stance from management, possibly due to broader market concerns or personal portfolio adjustments.

02

Market read

While insider selling can signal caution, the company's recent earnings beat and sector stability suggest limited immediate downside. Traders should weigh insider activity against technical signals and broader market conditions.

03

What to watch

Market-wide volatility, macroeconomic conditions, and upcoming earnings reports could influence stock movement independently of insider activity.

Timing: short-term

Background

USANA Health Sciences recently reported quarterly earnings exceeding expectations, yet insider Gilbert Fuller sold 1,058 shares at an average price of $17.00, near the 52-week low.

Company-level read

Ticker impact

$USNANeutralMedium confidence
Context

The insider selling activity and stock performance suggest cautious outlook.

Expected impact

Potential short-term decline or sideways movement; long-term impact uncertain.

Evidence & confidence

Insider sales can be a normal part of portfolio management and do not always indicate negative outlook. The stock traded near its 52-week low despite earnings beats, suggesting other factors are influencing price.

Market effects

The consumer health and life sciences sector may experience minor volatility due to insider activity in USNA.

Limited; USNA's market cap and trading volume suggest minimal regional impact.

Negligible; USNA's activity is unlikely to influence global markets significantly.

Counterpoint

Insider selling may be routine profit-taking and not indicative of future performance; the company's earnings beat suggests underlying strength.

Key entities

  • Gilbert Fuller

    Director of USANA Health Sciences who sold 1,058 shares.

  • USANA Health Sciences

    A company in the life sciences sector specializing in consumer health products.

Related articles

$USNAHigh

USANA HEALTH SCIENCES INC (USNA): Results of Operations and Financial Condition

USANA HEALTH SCIENCES INC (USNA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q22026earningsreleaseex991.htm EX-99.1 Document USANA Health Sciences Reports Second Quarter 2026 Results Company Continues Evolution to a Diversified, Omnichannel Health and Wellness Business SALT LAKE CITY, August 4, 2026 (BUSINESS WIRE)—USANA Health Sciences, Inc. (N

$ETNMed

Eaton Gains on $7-Million Contract

Eaton (NYSE:ETN) said the U.S. Air Force Research Laboratory awarded it a $7 million, 24-month contract to use quantum computing, machine learning, and advanced visualization to improve power grid resilience and protection. The work, with Infleqtion and Penn State, targets detection and response to multiple concurrent physical and cyber threats, addressing NERC N-2 contingency requirements.

$XOMMed

ExxonMobil awards McDermott engineering work for Rovuma LNG

ExxonMobil Moçambique Limitada issued McDermott Energy Solutions (UK) a letter of intent for limited engineering and procurement work on Rovuma LNG Phase 1 midstream development. The award supports planning ahead of a final investment decision expected in 2026. Rovuma LNG targets 12 modular trains totaling 18.6 mtpa, with start-up in 2031. ExxonMobil says the 30-year project could generate about $150B in revenues for Mozambique’s government.

$ESLTMed

Serbia to open joint UAV factory with Elbit in September

Serbia President Aleksandar Vucic said Serbia will open a joint UAV factory with Elbit Systems, with inauguration expected Sept 15-20. Elbit will hold 51% and Serbia’s state arms firm SDPR 49%. The factory relates to a five-year contract covering precision rockets and unmanned systems, plus ISTAR, digitization and upgrades.

$NOCMed

The Pentagon is urging defense contractors to urgently ramp up weapons production – WP

The U.S. Department of Defense, according to The Washington Post, asked defense contractors to submit within 21 days production and delivery schedules for critical systems, citing depleted stockpiles. CSIS estimates cite heavy early use of missiles and falling Patriot and THAAD inventories. The Pentagon is working with Northrop Grumman and Lockheed Martin, including a $58.6B deal to triple PAC-3 output by 2030, pending a stalled $1.15T defense budget.